Cargando…
Lipoxin A(4) suppresses angiotensin II type 1 receptor autoantibody in preeclampsia via modulating caspase-1
Preeclampsia (PE) remains a leading cause of maternal and neonatal morbidity and mortality. Numerous studies have shown that women with PE develop autoantibody, termed angiotensin II type 1 receptor autoantibody (AT1-AA), and key features of the disease result from it. Emerging evidence has indicate...
Autores principales: | Liu, Haojing, Cheng, Fangxiong, Xu, Qiang, Huang, Wei, Wang, Sumei, Sun, Rui, Ye, Duyun, Zhang, Dongxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6992755/ https://www.ncbi.nlm.nih.gov/pubmed/32001671 http://dx.doi.org/10.1038/s41419-020-2281-y |
Ejemplares similares
-
Glucocorticoid Exposure Induces Preeclampsia via DampeningLipoxin A(4), an Endogenous Anti-Inflammatory and Proresolving Mediator
por: Liu, Haojing, et al.
Publicado: (2020) -
Colorectal Cancer Is Associated with a Deficiency of Lipoxin A(4), an Endogenous Anti-inflammatory Mediator
por: Liu, Haojing, et al.
Publicado: (2019) -
Lipoxins: A Novel Regulator in Embryo Implantation
por: Xiong, Jing, et al.
Publicado: (2011) -
Hepatitis B Virus Infection Dampens CtIP Expression in Hepatoma Cell
por: Zhang, Dongxin, et al.
Publicado: (2018) -
Placental Vacuolar ATPase Function Is a Key Link between Multiple Causes of Preeclampsia
por: Zhang, Dongxin, et al.
Publicado: (2013)